Logo image of USM

US CELLULAR CORP (USM) Stock Fundamental Analysis

USA - NYSE:USM - US9116841084 - Common Stock

77.01 USD
+2.76 (+3.72%)
Last: 8/11/2025, 8:07:46 PM
77.9 USD
+0.89 (+1.16%)
After Hours: 8/11/2025, 8:07:46 PM
Fundamental Rating

3

USM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 22 industry peers in the Wireless Telecommunication Services industry. USM has only an average score on both its financial health and profitability. USM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

USM had positive earnings in the past year.
USM had a positive operating cash flow in the past year.
USM had positive earnings in 4 of the past 5 years.
USM had a positive operating cash flow in each of the past 5 years.
USM Yearly Net Income VS EBIT VS OCF VS FCFUSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

USM has a Return On Assets of -0.38%. This is in the lower half of the industry: USM underperforms 72.73% of its industry peers.
The Return On Equity of USM (-0.85%) is worse than 72.73% of its industry peers.
USM's Return On Invested Capital of 1.10% is in line compared to the rest of the industry. USM outperforms 40.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USM is below the industry average of 5.80%.
The last Return On Invested Capital (1.10%) for USM is above the 3 year average (1.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROIC 1.1%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
USM Yearly ROA, ROE, ROICUSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

The Operating Margin of USM (3.58%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of USM has grown nicely.
Looking at the Gross Margin, with a value of 57.26%, USM is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
In the last couple of years the Gross Margin of USM has remained more or less at the same level.
Industry RankSector Rank
OM 3.58%
PM (TTM) N/A
GM 57.26%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
USM Yearly Profit, Operating, Gross MarginsUSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USM is destroying value.
The number of shares outstanding for USM remains at a similar level compared to 1 year ago.
USM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, USM has an improved debt to assets ratio.
USM Yearly Shares OutstandingUSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USM Yearly Total Debt VS Total AssetsUSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

USM has an Altman-Z score of 1.53. This is a bad value and indicates that USM is not financially healthy and even has some risk of bankruptcy.
USM has a Altman-Z score of 1.53. This is in the better half of the industry: USM outperforms 72.73% of its industry peers.
USM has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as USM would need 8.09 years to pay back of all of its debts.
The Debt to FCF ratio of USM (8.09) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.62 indicates that USM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, USM perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Altman-Z 1.53
ROIC/WACC0.14
WACC7.62%
USM Yearly LT Debt VS Equity VS FCFUSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.70 indicates that USM should not have too much problems paying its short term obligations.
USM has a better Current ratio (1.70) than 63.64% of its industry peers.
A Quick Ratio of 1.48 indicates that USM should not have too much problems paying its short term obligations.
USM has a better Quick ratio (1.48) than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.48
USM Yearly Current Assets VS Current LiabilitesUSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1

3. Growth

3.1 Past

USM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.32%.
USM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.19% yearly.
The Revenue has decreased by -3.48% in the past year.
The Revenue has been decreasing by -1.29% on average over the past years.
EPS 1Y (TTM)7.32%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%80%
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-1.19%

3.2 Future

USM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.20% yearly.
The Revenue is expected to decrease by -42.63% on average over the next years. This is quite bad
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
EPS Next 5Y0.2%
Revenue Next Year-2.84%
Revenue Next 2Y-1.42%
Revenue Next 3Y-1.07%
Revenue Next 5Y-42.63%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
USM Yearly Revenue VS EstimatesUSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
USM Yearly EPS VS EstimatesUSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 87.51, USM can be considered very expensive at the moment.
72.73% of the companies in the same industry are cheaper than USM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.13, USM is valued quite expensively.
A Price/Forward Earnings ratio of 69.32 indicates a quite expensive valuation of USM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USM indicates a slightly more expensive valuation: USM is more expensive than 72.73% of the companies listed in the same industry.
USM is valuated expensively when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 87.51
Fwd PE 69.32
USM Price Earnings VS Forward Price EarningsUSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

USM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. USM is more expensive than 63.64% of the companies in the same industry.
USM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. USM is more expensive than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.54
EV/EBITDA 11.58
USM Per share dataUSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USM's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.49
PEG (5Y)N/A
EPS Next 2Y25.09%
EPS Next 3Y21.15%

4

5. Dividend

5.1 Amount

USM has a Yearly Dividend Yield of 7.49%, which is a nice return.
Compared to an average industry Dividend Yield of 8.74, USM pays a better dividend. On top of this USM pays more dividend than 81.82% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, USM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.49%

5.2 History

USM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
USM Yearly Dividends per shareUSM Yearly Dividends per shareYearly Dividends per share 2025 5 10 15 20

5.3 Sustainability

DP0%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
USM Yearly Income VS Free CF VS DividendUSM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

US CELLULAR CORP

NYSE:USM (8/11/2025, 8:07:46 PM)

After market: 77.9 +0.89 (+1.16%)

77.01

+2.76 (+3.72%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)10-30 2025-10-30/bmo
Inst OwnersN/A
Inst Owner Change0.45%
Ins OwnersN/A
Ins Owner Change-9.5%
Market Cap6.55B
Revenue(TTM)3.77B
Net Income(TTM)-39000000
Analysts75.56
Price Target76.61 (-0.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.49%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-20 2025-08-20 (23)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)76.69%
Min EPS beat(2)-39.44%
Max EPS beat(2)192.83%
EPS beat(4)3
Avg EPS beat(4)73.51%
Min EPS beat(4)-39.44%
Max EPS beat(4)192.83%
EPS beat(8)5
Avg EPS beat(8)113.75%
EPS beat(12)6
Avg EPS beat(12)56.53%
EPS beat(16)8
Avg EPS beat(16)47.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-2.52%
Revenue beat(12)3
Avg Revenue beat(12)-2.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.08%
PT rev (1m)2.74%
PT rev (3m)1.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 87.51
Fwd PE 69.32
P/S 1.76
P/FCF 18.54
P/OCF 7.79
P/B 1.43
P/tB 1636.46
EV/EBITDA 11.58
EPS(TTM)0.88
EY1.14%
EPS(NY)1.11
Fwd EY1.44%
FCF(TTM)4.15
FCFY5.39%
OCF(TTM)9.88
OCFY12.83%
SpS43.66
BVpS53.94
TBVpS0.05
PEG (NY)5.49
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.12%
ROICexgc 2.19%
OM 3.58%
PM (TTM) N/A
GM 57.26%
FCFM 9.51%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
ROICexc(3y)1.07%
ROICexc(5y)1.37%
ROICexgc(3y)2.08%
ROICexgc(5y)2.45%
ROCE(3y)1.33%
ROCE(5y)1.64%
ROICexgc growth 3Y-6.62%
ROICexgc growth 5Y1.42%
ROICexc growth 3Y-9.23%
ROICexc growth 5Y-3.33%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Debt/EBITDA 3.55
Cap/Depr 73.45%
Cap/Sales 13.12%
Interest Coverage 250
Cash Conversion 105.53%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.48
Altman-Z 1.53
F-Score5
WACC7.62%
ROIC/WACC0.14
Cap/Depr(3y)121.94%
Cap/Depr(5y)166.9%
Cap/Sales(3y)20.71%
Cap/Sales(5y)28.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.32%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%80%
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y21.15%
EPS Next 5Y0.2%
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-1.19%
Revenue Next Year-2.84%
Revenue Next 2Y-1.42%
Revenue Next 3Y-1.07%
Revenue Next 5Y-42.63%
EBIT growth 1Y-23.56%
EBIT growth 3Y-8.78%
EBIT growth 5Y2.21%
EBIT Next Year20168.2%
EBIT Next 3Y476.6%
EBIT Next 5Y95.74%
FCF growth 1Y406.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.47%
OCF growth 3Y3.26%
OCF growth 5Y4.05%

US CELLULAR CORP / USM FAQ

What is the fundamental rating for USM stock?

ChartMill assigns a fundamental rating of 3 / 10 to USM.


Can you provide the valuation status for US CELLULAR CORP?

ChartMill assigns a valuation rating of 1 / 10 to US CELLULAR CORP (USM). This can be considered as Overvalued.


How profitable is US CELLULAR CORP (USM) stock?

US CELLULAR CORP (USM) has a profitability rating of 4 / 10.


How financially healthy is US CELLULAR CORP?

The financial health rating of US CELLULAR CORP (USM) is 4 / 10.


Can you provide the expected EPS growth for USM stock?

The Earnings per Share (EPS) of US CELLULAR CORP (USM) is expected to grow by 15.94% in the next year.